Cargando…

Associations of oxygenated hemoglobin with disease burden and prognosis in stable COPD: Results from COSYCONET

We studied whether in patients with stable COPD blood gases (BG), especially oxygenated hemoglobin (OxyHem) as a novel biomarker confer information on disease burden and prognosis and how this adds to the information provided by the comorbidity pattern and systemic inflammation. Data from 2137 patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trudzinski, F. C., Jörres, R. A., Alter, P., Kahnert, K., Waschki, B., Herr, C., Kellerer, C., Omlor, A., Vogelmeier, C. F., Fähndrich, S., Watz, H., Welte, T., Jany, B., Söhler, S., Biertz, F., Herth, F., Kauczor, H.-U., Bals, R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324620/ https://www.ncbi.nlm.nih.gov/pubmed/32601330 http://dx.doi.org/10.1038/s41598-020-67197-x

Ejemplares similares

The impact of COPD on polyneuropathy: results from the German COPD cohort COSYCONET
por: Kahnert, K., et al.
Publicado: (2020)

Impact of the COVID-19 pandemic on the behaviour and health status of patients with COPD: results from the German COPD cohort COSYCONET
por: Kahnert, Kathrin, et al.
Publicado: (2021)

Was haben wir aus der deutschen COPD-Kohorte COSYCONET gelernt und wie geht es weiter?
por: Kahnert, Kathrin, et al.
Publicado: (2022)

Prevalence of cardiac comorbidities, and their underdetection and contribution to exertional symptoms in COPD: results from the COSYCONET cohort
por: Alter, Peter, et al.
Publicado: (2019)

Clinical factors linked to the type of respiratory medication in COPD: results from the COSYCONET cohort
por: Alter, Peter, et al.
Publicado: (2023)

Prediction of air trapping or pulmonary hyperinflation by forced spirometry in COPD patients: results from COSYCONET
por: Alter, Peter, et al.
Publicado: (2020)

Treatment of COPD Groups GOLD A and B with Inhaled Corticosteroids in the COSYCONET Cohort – Determinants and Consequences
por: Lutter, Johanna I, et al.
Publicado: (2021)

Adherence To Respiratory And Nonrespiratory Medication In Patients With COPD: Results Of The German COSYCONET Cohort
por: Königsdorfer, Norbert, et al.
Publicado: (2019)

Prediction of lung emphysema in COPD by spirometry and clinical symptoms: results from COSYCONET
por: Kellerer, Christina, et al.
Publicado: (2021)

Sex-specific associations of comorbidome and pulmorbidome with mortality in chronic obstructive pulmonary disease: results from COSYCONET
por: Trudzinski, Franziska C., et al.
Publicado: (2022)

Impact of Education on COPD Severity and All-Cause Mortality in Lifetime Never-Smokers and Longtime Ex-Smokers: Results of the COSYCONET Cohort
por: Lutter, Johanna I, et al.
Publicado: (2020)

Relationship of hyperlipidemia to comorbidities and lung function in COPD: Results of the COSYCONET cohort
por: Kahnert, Kathrin, et al.
Publicado: (2017)

Disease Progression and Age as Factors Underlying Multimorbidity in Patients with COPD: Results from COSYCONET
por: Alter, Peter, et al.
Publicado: (2022)

The association of cognitive functioning as measured by the DemTect with functional and clinical characteristics of COPD: results from the COSYCONET cohort
por: von Siemens, Sarah Marietta, et al.
Publicado: (2019)

Basic Determinants of Disease Knowledge in COPD Patients: Results from COSYCONET
por: Fischer, Carolina, et al.
Publicado: (2022)

Lower Prevalence of Osteoporosis in Patients with COPD Taking Anti-Inflammatory Compounds for the Treatment of Diabetes: Results from COSYCONET
por: Kahnert, Kathrin, et al.
Publicado: (2021)

Effect of COPD severity and comorbidities on the result of the PHQ-9 tool for the diagnosis of depression: results from the COSYCONET cohort study
por: von Siemens, Sarah Marietta, et al.
Publicado: (2019)

Transfer factor for carbon monoxide in patients with COPD and diabetes: results from the German COSYCONET cohort
por: Kahnert, Kathrin, et al.
Publicado: (2017)

Longitudinal stability of blood eosinophil count strata in the COPD COSYCONET cohort
por: Greulich, Timm, et al.
Publicado: (2018)

Consequences of chronic kidney disease in chronic obstructive pulmonary disease
por: Trudzinski, Franziska C., et al.
Publicado: (2019)

Gender-specific differences in COPD symptoms and their impact for the diagnosis of cardiac comorbidities
por: Trudzinski, Franziska C., et al.
Publicado: (2021)

Cardiovascular predictors of mortality and exacerbations in patients with COPD
por: Alter, Peter, et al.
Publicado: (2022)

Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach
por: Kahnert, Kathrin, et al.
Publicado: (2018)

Standardized airway wall thickness Pi10 from routine CT scans of COPD patients as imaging biomarker for disease severity, lung function decline, and mortality
por: Kahnert, Kathrin, et al.
Publicado: (2023)

Effects of airway obstruction and hyperinflation on electrocardiographic axes in COPD
por: Alter, Peter, et al.
Publicado: (2019)

Reduced decline of lung diffusing capacity in COPD patients with diabetes and metformin treatment
por: Kahnert, Kathrin, et al.
Publicado: (2022)

Health-related quality of life associates with change in FEV(1) in COPD: results from the COSYCONET cohort
por: Lutter, Johanna I., et al.
Publicado: (2020)

Cardiovascular risk in patients with alpha-1-antitrypsin deficiency
por: Fähndrich, Sebastian, et al.
Publicado: (2017)

Relationship of spirometric, body plethysmographic, and diffusing capacity parameters to emphysema scores derived from CT scans
por: Kahnert, Kathrin, et al.
Publicado: (2018)

The contribution of symptoms and comorbidities to the economic impact of COPD: an analysis of the German COSYCONET cohort
por: Wacker, Margarethe E, et al.
Publicado: (2017)

IgE is associated with exacerbations and lung function decline in COPD
por: Lommatzsch, Marek, et al.
Publicado: (2022)

Determinants of healthcare utilization and costs in COPD patients: first longitudinal results from the German COPD cohort COSYCONET
por: Byng, Danalyn, et al.
Publicado: (2019)

Low miR-150-5p and miR-320b Expression Predicts Reduced Survival of COPD Patients
por: Keller, Andreas, et al.
Publicado: (2019)

Relative impact of COPD and comorbidities on generic health-related quality of life: a pooled analysis of the COSYCONET patient cohort and control subjects from the KORA and SHIP studies
por: Wacker, Margarethe E., et al.
Publicado: (2016)

Genome-wide MicroRNA Expression Profiles in COPD: Early Predictors for Cancer Development
por: Keller, Andreas, et al.
Publicado: (2018)

Influence of body mass on predicted values of static hyperinflation in COPD
por: Alter, Peter, et al.
Publicado: (2018)

Systematic Analysis of Self-Reported Comorbidities in Large Cohort Studies – A Novel Stepwise Approach by Evaluation of Medication
por: Lucke, Tanja, et al.
Publicado: (2016)

Was man von Viren lernen kann
por: Welte, T., et al.
Publicado: (2019)

Differences in the Measurement of Functional Residual Capacity Between Body Plethysmographs of Two Manufacturers
por: Alter, Peter, et al.
Publicado: (2022)

Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function
por: Waschki, Benjamin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8qiou8at9nmrc793lqit1qoolh